Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up — Biospace
Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up
Biospace
View source article
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up — Biospace